Anthem Biosciences IPO allotment status online check can be done through the websites of BSE and NSE, along with the official ...

Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...

Anthem Biosciences IPO allotment status is finalised and investors now shift focus towards the Anthem Biosciences IPO listing ...

Colossal Biosciences, powered by AI and amplified by Hollywood's megaphone, is proving that the story of extinction doesn't ...

Anthem Biosciences IPO Allotment: The IPO of Anthem Biosciences is now heading toward its next big step and that is ‘share ...

The issue was oversubscribed 63.86 times overall, with the retail investor portion subscribed 5.64 times and the ...

This strong response from different investor categories highlights the market's confidence in ABL's potential as a publicly ...

Anthem Biosciences IPO oversubscribed, set to list with 20-25% gain, raising ₹1,016 crore from anchor investors.

A species of huge, flightless bird that once inhabited New Zealand disappeared around 600 years ago, shortly after human ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

Waters and BD will merge biosciences and diagnostics in a $17.5B deal via Reverse Morris Trust, creating a life sciences ...